Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8582641 | 1.00 | ALDH1A1 (0.45) | ALDH1A1CES2CES1ADRB2ADRB1 | |
| SCHEMBL3733393 | 0.98 | ALDH1A1 (0.42) | ALDH1A1CES2CES1ADRB2ADRB1 | |
| SCHEMBL3152801 | 0.94 | SMN1; SMN2 (0.41) | ALDH1A1ADRB2ADRB1ADRB3MAPT | |
| SCHEMBL9034576 | 0.89 | — | — | |
| SCHEMBL2907680 | 0.88 | ALDH1A1 (0.42) | ALDH1A1CES2CES1ADRB2ADRB1 | |
| SCHEMBL8584529 | 0.88 | ALDH1A1 (0.42) | ALDH1A1CES2CES1ADRB2ADRB1 | |
| SCHEMBL8845363 | 0.87 | ALDH1A1 (0.50) | ALDH1A1CES2CES1ADRB2ADRB1 | |
| SCHEMBL205737 | 0.87 | ALDH1A1 (0.50) | ALDH1A1CES2CES1ADRB2ADRB1 | |
| SCHEMBL2835530 | 0.86 | ALDH1A1 (0.41) | ALDH1A1CES2CES1ADRB2ADRB1 | |
| SCHEMBL3733817 | 0.86 | ADRB2 (0.41) | ALDH1A1CES2CES1ADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3681871-A1 | COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY | Azevan Pharmaceuticals, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| US-20200071617-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | DIC CORPORATION (JP) | 2020-03-05 | — | — | US | disclosed |
| WO-2019055913-A1 | COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY | AZEVAN PHARMACEUTICALS, INC. (US) | 2019-03-21 | — | — | WO | disclosed |
| WO-2018165266-A1 | COMPOSITIONS AND METHODS FOR TREATING DRY EYE DISEASES | CEMPRA PHARMACEUTICALS, INC. (US) | 2018-09-13 | — | — | WO | disclosed |
| EP-3122743-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | Azevan Pharmaceuticals, Inc. (US) | 2017-02-01 | — | — | EP | disclosed |
| EP-3105234-A1 | COMPOSITIONS AND METHODS FOR TREATING DIABETES AND LIVER DISEASES | Cempra Pharmaceuticals, Inc. (US) | 2016-12-21 | — | — | EP | disclosed |
| WO-2016153874-A1 | COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE | PURDUE RESEARCH FOUNDATION (US) | 2016-09-29 | — | — | WO | disclosed |
| EP-3003303-A1 | PPAR GAMMA MODULATORS FOR TREATING CYSTIC DISEASES | Indiana University Research And Technology Corporation (US) | 2016-04-13 | — | — | EP | disclosed |
| EP-2968801-A1 | METHODS FOR TREATING RESPIRATORY DISEASES AND FORMULATIONS THEREFOR | Cempra Pharmaceuticals, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2961764-A1 | PROCESSES FOR PREPARING TUBULYSINS | Endocyte, Inc. (US) | 2016-01-06 | — | — | EP | disclosed |
| WO-1997030027-A1 | BETA-THIOPROPIONYL-AMINOACID DERIVATIVES AND THEIR USE AS BETA-LACTAMASE INHIBITORS | SMITHKLINE BEECHAM PLC (GB) | 1997-08-21 | — | — | WO | disclosed |
| WO-1997010225-A1 | PYRROLIDINE AND THIAZOLE DERIVATIVES WITH ANTIBACTERIAL AND METALLO-BETA-LACTAMASE INHIBITORY PROPERTIES | SMITHKLINE BEECHAM PLC (GB) | 1997-03-20 | — | — | WO | disclosed |
| EP-0758240-A1 | PHARMACEUTICAL FORMULATIONS CONTAINING A BETA-LACTAMASE INHIBITING PENEM IN COMBINATION WITH A BETA-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | SMITHKLINE BEECHAM PLC (GB) | 1997-02-19 | — | — | EP | disclosed |
| WO-1996017847-A1 | PROCESS FOR THE PREPARATION OF CEPHALOSPORINS AND ANALOGUES | PFIZER INC. (US) | 1996-06-13 | — | — | WO | disclosed |
| EP-0689540-A1 | CARBACEPHALOSPORIN COMPOUND, THEIR PREPARATION AND USE | PFIZER INC. (US) | 1996-01-03 | — | — | EP | disclosed |
| EP-0651755-A1 | CEPHALOSPORINS AND 1-CARBA-1-DETHIA CEPHALOSPORINS | PFIZER INC. (US) | 1995-05-10 | — | — | EP | disclosed |
| WO-1994021633-A1 | CARBACEPHALOSPORIN COMPOUND, THEIR PREPARATION AND USE | SMITHKLINE BEECHAM PLC (GB) | 1994-09-29 | — | — | WO | disclosed |
| EP-0211656-A2 | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1987-02-25 | — | — | EP | disclosed |
| EP-0210815-A2 | 6-Beta-(alpha-etherified oxyimino)-acylamino penicillanic-acid derivatives, their preparation and use | BEECHAM GROUP PLC (GB) | 1987-02-04 | — | — | EP | disclosed |
| US-4477447-A | ANTIBIOTIC, BACTERICIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-16 | — | — | US | disclosed |